By expenditures
| Name | Title | Type |
|---|---|---|
| Rachel Almen | PARTNER | Auditee |
| Kendra Trupe | BUSINESS MANAGER | Auditee |
| Matt Laughlin | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 309600 | 2023 | 2024-06-24 | Brady Martz & Associates PC | $884,129 |
| 305884 | 2022 | 2024-05-09 | Hurtt Mortenson and Rygh | $829,419 |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 309600 | 2023 | 2024-06-24 | 978089 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978088 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978087 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978086 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978085 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978084 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978083 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978082 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978081 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978080 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978079 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978078 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 978077 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401647 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401646 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401645 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401644 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401643 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401642 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401641 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401640 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401639 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401638 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401637 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401636 | 2023-004 | Significant Deficiency | - | L |
| 309600 | 2023 | 2024-06-24 | 401635 | 2023-004 | Significant Deficiency | - | L |